SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000946644-15-000062
Filing Date
2015-09-02
Accepted
2015-09-02 16:28:13
Documents
2
Effectiveness Date
2015-09-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A hebfy2015definadditmatkast.htm DEFA14A 35254
2 hebfy2015definadditma_image1.jpg GRAPHIC 15266
  Complete submission text file 0000946644-15-000062.txt   57497
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-27072 | Film No.: 151089839
SIC: 2836 Biological Products, (No Diagnostic Substances)